Lonza Group AG (LZAGF)
Manufactures drugs and biologics for pharmaceutical and biotech companies worldwide.
$688.12+0.02%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-2.0%
The outlook
Lonza Group is trading above both its 50- and 200-day moving averages, positioning it in the upper half of its 52-week range. Analyst sentiment leans bullish overall. The stock carries a trailing P/E of 36.3, reflecting elevated valuation relative to recent earnings.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range64% of the way from its 52-week low to high
Market cap
$48.06B
52-wk high
$755.96
52-wk low
$565.14
50-day avg
$658.49
200-day avg
$666.33
Trailing P/E
36.3